Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib + Paclitaxel + Trastuzumab in HER2+ Metastatic Breast Cancer
NCT00272987Phase 3Terminated
- Sponsor
- Novartis
- Start
- Dec 2005
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of lapatinib in breast cancer, sponsored by Novartis. Started Dec 2005; status: terminated.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00272987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00272987.